Hereditary Cancer in Clinical Practice

Papers
(The H4-Index of Hereditary Cancer in Clinical Practice is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
CMMRD caused by PMS1 mutation in a sudanese consanguineous family33
Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer24
Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice16
Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline15
Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome14
A second hereditary cancer predisposition syndrome in a patient with lynch syndrome and three primary cancers14
A genome-wide association study in Swedish colorectal cancer patients with gastric- and prostate cancer in relatives13
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers11
Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals10
Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis10
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants10
0.017873048782349